Opioid-based micro and nanoparticulate formulations: alternative approach on pain management

Journal of Microencapsulation
André São PedroElaine Cabral Albuquerque

Abstract

Opioids have been used as the reference treatment on chronic pain. However, they are related to serious adverse effects which affect the patient compliance to treatment, as well as, his quality of life. Particulate formulations have been investigated as an alternative to improve opioid efficacy and safety. Summarise the available studies concerning micro and nanoencapsulated opioid formulations discussing their biopharmaceutical characteristics, such as composition, size, in vitro release, pharmacokinetic and antinociceptive profile. Papers available in 1995-2015 at Medline, Science Direct and Web of Science databases were collected and assessed. Searches were performed using varied combinations of the keywords of this work. Opioid-loaded particles showed prolonged drug release with maintenance of serum therapeutic concentrations and extended analgesia when compared with the free drugs. The side effects incidences were reduced or maintained the same. Particulate formulations can significantly increase both potency and safety profiles of opioids.

References

Aug 1, 1995·Anesthesiology·O R HungM Mezei
Oct 1, 1994·Anesthesia and Analgesia·G J GrantL Langerman
Apr 1, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·Z Y ZhangB Xiao
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Jul 20, 2000·Drug Development and Industrial Pharmacy·H C Chang, L C Li
Apr 20, 2001·Advanced Drug Delivery Reviews·W Mehnert, K Mäder
Aug 8, 2002·Journal of Drug Targeting·Jörg KreuterRenad Alyautdin
Dec 14, 2002·International Journal of Pharmaceutics·M BudaiPál Gróf
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Jacques R Caldwell
Mar 12, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·M E MoralesM A Ruiz
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Christophe Olivier
Mar 12, 2005·AAPS PharmSciTech·Mercedes Fernández-ArévaloMaria Angeles Holgado
Jul 6, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Dorien GroenendaalElizabeth C M de Lange
Sep 10, 2005·American Journal of Respiratory and Critical Care Medicine·Svetlana GelperinaLeonid Heifets
Oct 26, 2005·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Chris Pasero, Margo McCaffery
Jan 18, 2006·International Journal of Pharmaceutics·Justyna PietkiewiczMarcin Placzek
Aug 29, 2006·Journal of Pharmaceutical Sciences·Paola RussoAlessandra Rossi
Nov 1, 2006·International Journal of Pharmaceutics·M E MoralesV Gallardo
Dec 28, 2006·Biotechnology and Bioengineering·Daniel S Kohane
Jan 12, 2007·Current Pain and Headache Reports·Dorothy V HoltCindy J Wordell
Feb 13, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Catarina Pinto ReisFrancisco Veiga
Oct 26, 2007·Journal of Opioid Management·Gary M ReisfieldGeorge R Wilson
Jun 25, 2008·The Clinical Journal of Pain·Jane C Ballantyne, Naomi S Shin
Oct 1, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Medha D Joshi, Rainer H Müller
Nov 8, 2008·The AAPS Journal·Emily O Dumas, Gary M Pollack
Nov 11, 2008·International Journal of Pharmaceutics·Jana PardeikeRainer H Müller
Dec 6, 2008·Chemistry and Physics of Lipids·Eric Da SilvaDérick Rousseau
Jan 27, 2009·Colloids and Surfaces. B, Biointerfaces·José L AriasMa Adolfina Ruiz
Mar 13, 2009·Physical Chemistry Chemical Physics : PCCP·H Jelger Risselada, Siewert J Marrink
Apr 9, 2009·The Journal of Pharmacology and Experimental Therapeutics·Lisa Krugner-HigbyLesley J Smith
Jul 14, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jhi-Joung WangJia-You Fang
Sep 15, 2009·International Journal of Pharmaceutics·Sudhir S ChakravarthiDennis H Robinson
Nov 3, 2009·The Journal of Pain : Official Journal of the American Pain Society·Irene Tracey, M Catherine Bushnell
Nov 19, 2009·Journal of Pharmaceutical Sciences·Jia-You FangChao-Huang Chen
Nov 26, 2009·Journal of Nanoscience and Nanotechnology·Telli HekmataraJörg Kreuter
May 1, 2008·Indian Journal of Pharmaceutical Sciences·Jessy Shaji, V Patole
Jan 15, 2010·Drug Development and Industrial Pharmacy·Wiesław SawickiIlona Jakubowska

❮ Previous
Next ❯

Citations

Feb 26, 2019·Journal of Drug Targeting·Pankaj BidveVinod Tiwari
Jan 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Shumaila RazzaqueBien Tan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.